Market revenue in 2023 | USD 322.7 million |
Market revenue in 2030 | USD 653.5 million |
Growth rate | 10.6% (CAGR from 2023 to 2030) |
Largest segment | Serum-free media |
Fastest growing segment | Serum-free Media |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Serum-free Media, Classical Media, Stem Cell Culture Media, Chemically Defined Media, Specialty Media, Other Cell Culture Media |
Key market players worldwide | Sartorius AG, Danaher Corp, Merck KGaA, Thermo Fisher Scientific Inc, FUJIFILM Holdings Corp, Lonza Group Ltd, BD, STEMCELL Technologies, PromoCell GmbH |
Serum-free media was the largest segment with a revenue share of 35.95% in 2023. Horizon Databook has segmented the Germany cell culture media market based on serum-free media, classical media, stem cell culture media, chemically defined media, specialty media, other cell culture media covering the revenue growth of each sub-segment from 2018 to 2030.
In Europe, Germany is the largest producer of biopharmaceuticals approved in the EU, and biopharmaceutical sales account for over 30% of the overall pharmaceutical sales. Increased production of APIs for monoclonal antibodies and biologics is creating a lucrative market for cell culture media offerings.
Furthermore, growth of medical biotechnology is fueling the market growth. Moreover, a high number of COVID-19 cases and extensive R&D activities by regional players to develop novel vaccines for the disease are anticipated to create significant demand for cell culture media solutions for research & clinical applications. Major players in the market include Promo Cell GmbH, Capricorn Scientific GmbH, Sartorius AG, and Merck KGAA.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account